The Azithromycin Pro-Drug CSY5669 Boosts Bacterial Killing While Attenuating Lung Inflammation Associated with Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus
Anno Saris(Leiden University Medical Center), Tom van der Poll(Academic Medical Center)
Cited by 6
Related Papers
Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study
|Clinical Infectious Diseases|2014|773
Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study
|The Lancet Respiratory Medicine|2017|632
Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis
|Nature Immunology|2016|615